| Fibrolamellar Carcinoma studied in …STUDIED_INderived21 of 21show fewer |
|---|
| → studied in | NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04380545Phase 1/Phase 2 · recruiting Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer · condition mapped CURATED_BROADER · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789198Phase 1 · recruiting Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA · condition mapped ALIAS · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06620302Phase 1/Phase 2 · suspended Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma · condition mapped CURATED_BROADER · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05468359Phase 1/Phase 2 · recruiting Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860272Phase 1 · active not recruiting Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134559Phase 2 · recruiting Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06027086Phase 1/Phase 2 · recruiting DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) · condition mapped ALIAS · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248569Phase 1 · recruiting DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma · condition mapped ALIAS · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874519completed Registry to Collect Health Information Related to Fibrolamellar Cancer · condition mapped CURATED_BROADER · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06521567Phase 1/Phase 2 · active not recruiting A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159989Phase 1 · completed Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541652recruiting A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05603572Phase 1/Phase 2 · suspended KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02234986Phase 2 · completed A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma · condition mapped CURATED_BROADER · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05937295Phase 1 · recruiting FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition · condition mapped ALIAS · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05681949NA · unknown Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards · condition mapped ALIAS · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642186Phase 2 · completed Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02702960Phase 2 · withdrawn Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) · condition mapped ALIAS · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01215565Phase 2 · terminated Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma · condition mapped ALIAS · 21 trials mapped (12 active) | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |